Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Although elevated activity of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) has been proposed to mediate comorbid depression in inflammatory disorders, its causative role has never been tested. We report that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests. Blockade of IDO activation either indirectly with the anti-inflammatory tetracycline derivative minocycline, that attenuates LPS-induced expression of proinflammatory cytokines, or directly with the IDO antagonist 1-methyltryptophan (1-MT), prevents development of depressive-like behavior. Both minocycline and 1-MT normalize the kynurenine/tryptophan ratio in the plasma and brain of LPS-treated mice without changing the LPS-induced increase in turnover of brain serotonin. Administration of L-kynurenine, a metabolite of tryptophan that is generated by IDO, to naive mice dose dependently induces depressive-like behavior. These results implicate IDO as a critical molecular mediator of inflammation-induced depressive-like behavior, probably through the catabolism of tryptophan along the kynurenine pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depressive-like behaviors in rodents are mediated by an enzyme that degrades tryptophan, called indoleamine 2,3dioxygenase (IDO; O'Connor et al., 2009; see also Maes et al., 2011)”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as O'Connor et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies have shown that inflammation promotes a pattern of behavior known as sickness behavior that includes symptoms of depression, such as fatigue, anhedonia, and social withdrawal.[10,11]”
From SUICIDAL IDEATION IS ASSOCIATED WITH ELEVATED INFLAMMATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: Research Article: Suicidal Ideation and Inflammation (2013) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, blocking glutamate receptors with ketamine or inhibiting IDO activity protects mice from LPS- or stress-induced depressive-like behaviour but leaves the inflammatory response intact85,86.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“In preclinical models, LPS-induced depressive behavior is mediated by IDO activation (O’Connor et al., 2009).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as O’Connor et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Self-citationPrevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Self-citation
Cited by
Items 701–800 of 1,001
Fujii, C., Zorumski, C. F., & Izumi, Y. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.391334 · Cited by 26
“It is thought that increased IDO enzymatic activity results in a decrease in tryptophan concentration, thereby interfering with the synthesis of serotonin (Booij et al., 2003; O’Connor et al., 2009).”
InfluentialAn, L., Li, J., Yu, S., Xue, R., Yu, N.-J., Chen, H., Zhang, L., Zhao, N., Li, Y., & Zhang, Y. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.01.022 · Cited by 26
Fu, Y., Zhang, F., Zhang, L., Liu, H., Zhao, Z., Wen, X., Wu, J. H., Qi, D., Sun, Y., Du, Y., et al. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0039-8 · Cited by 26
Controversies about a common etiology for eating and mood disorders
Rossetti, C., Halfon, O., & Boutrel, B. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.01205 · Cited by 30
Lin, J., Fang, S., Tang, S., Hu, M. Y., Long, Y., Ghosh, A., Sun, H., Kong, L., & Hong, H. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.145 · Cited by 28
Beheshti, F., Hashemzehi, M., Sabeti, N., Sadr, S. H., & Hosseini, M. (2018) · Cytokine · doi:10.1016/j.cyto.2018.10.005 · Cited by 25
Alfaro, V. Y., Goldblatt, D. L., Ha, G. V., Munsell, M. F., Quinton, L. J., Walker, A. K., Dantzer, R., Varadhachary, A., Scott, B. L., Evans, S. E., et al. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00008 · Cited by 25
“Mice were examined twice daily by veterinarians blinded to their treatments and euthanized if found distressed or removed from their cages if found dead.”
BackgroundSelf-citationYang, T. Y., Jang, E. Y., Ryu, Y., Lee, G. W., Lee, E.-B., Chang, S., Lee, J. H., Koo, J. S., Yang, C. H., & Kim, H. Y. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2039-y · Cited by 25
“As the other possible mechanism, acupuncture may regulate the level of inflammatory cytokines produced by LPS. Peripheral administration of LPS induces inflammatory cytokines such as tumor necrosis factor (TNF) α, interleukin (IL)-1β, IL-6 [45, 46] which may produce depressive or anxiety-like behavior [14, 17, 47, 48].”
BackgroundCarregosa, D., Lončarević‐Vasiljković, N., Feliciano, R., Moura-Louro, D., Mendes, C. S., & dos Santos, C. N. (2024) · Journal of Inflammation · doi:10.1186/s12950-024-00412-y · Cited by 26
Morena, D., Lippi, M., Scopetti, M., Turillazzi, E., & Fineschi, V. (2025) · Diagnostics · doi:10.3390/diagnostics15131683 · Cited by 25
“…LPS administration, through various mechanisms other than neuroinflammation—including the regulation of cerebral vascular permeability [36] and tryptophan metabolism [113]—may play a role in the development of mental disorders, particularly depression, anxiety, and sickness behaviors [114–117].”
Lustgarten, M. S., & Fielding, R. A. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.003 · Cited by 25
“Similarly, IFN-γ polarizes M1 macrophages, which are involved in mechanisms that allow FAPs to differentiate, or to undergo apoptosis (Wehling-Henricks et al., 2016).”
BackgroundInfluentialMygind, L., Bergh, M. S., Tejsi, V., Vaitheeswaran, R., Lambertsen, K. L., Finsen, B. R., & Metaxas, A. (2021) · Cells · doi:10.3390/cells10030608 · Cited by 25
Schmidt, E. K. A., Raposo, P. J. F., Madsen, K. L., Fenrich, K. K., Kabarchuk, G., & Fouad, K. (2021) · Biology · doi:10.3390/biology10040254 · Cited by 28
“Reducing kynurenine concentrations by blocking indoleamine 2,3-dioxygenase (the rate-limiting enzyme in the kynurenine pathway of tryptophan metabolism [73]) has also been shown to block lipopolysaccharide (LPS) induced depressive-like behaviour in rodents [74].”
BackgroundGuo, L., Gao, T., Gao, C., Jia, X., Ni, J., Han, C., & Wang, Y. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113344 · Cited by 27
Shishkina, G. T., Kalinina, T. S., Gulyaeva, N. V., Lanshakov, D. A., & Дыгало, Н. Н. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921060043 · Cited by 25
“Peripheral administration of LPS activates IDO and induces depression like behavior [67].”
BackgroundKong, Y., He, G., Zhang, X., & Li, J. (2021) · Brain Sciences · doi:10.3390/brainsci11111514 · Cited by 25
“In addition, depression-like behaviors are recapitulated by the acute infection of lipopolysaccharide (LPS) [10], and these behaviors are eliminated by antidepressant treatment before the LPS exposure [11].”
BackgroundEvolutionary Aspects of Infections: Inflammation and Sickness Behaviors
Dantzer, R. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_363 · Cited by 51
Self-citationMallik, S. B., Mudgal, J., Kinra, M., Hall, S., Grant, G. D., Anoopkumar‐Dukie, S., Nampoothiri, M., Zhang, Y., & Arora, D. S. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01267-7 · Cited by 25
“The initial phase of first 2–4 h is the “sickness behaviour”, where the animals mainly express severe lack of exploratory behaviour, bradykinesia, increased body temperature and lack of appetite (Painsipp et al. 2011; O’Connor et al., 2009).”
BackgroundConverged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics
Bajaj, S., & Mahesh, R. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09170-1 · Cited by 28
“Likewise, in a study, celecoxib with anti-depressant showed better efficacy than placebo combined with an antidepressant [125].”
Deng, Y., Zhao, M., Xu, T., Jin-Hou, & Li, X. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0246-y · Cited by 24
Korte-Bouws, G. A. H., van Heesch, F., Westphal, K. G. C., Ankersmit, L. M. J., van Oosten, E., Güntürkün, O., & Korte, S. M. (2018) · Pharmaceuticals · doi:10.3390/ph11030066 · Cited by 27
“Furthermore, it has been shown that LPS treatment caused an increase in brain tryptophan levels [22].”
Bottoms up: the role of gut microbiota in brain health
Radisavljevic, N., Cirstea, M., & Brett Finlay, B. (2019) · Environmental Microbiology · doi:10.1111/1462-2920.14506 · Cited by 22
Latent toxoplasmosis and psychiatric symptoms – A role of tryptophan metabolism?
Bay-Richter, C., Buttenschøn, H. N., Mors, O. N., Eskelund, A., Budac, D. P., Kærlev, L., & Wegener, G. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.12.016 · Cited by 27
Animal models of major depressive disorder and the implications for drug discovery and development
Demin, K. A., Sysoev, M., Chernysh, M. V., Savva, A. K., Koshiba, M., Wappler-Guzzetta, E. A., Song, C., de Abreu, M. S., Leonard, B. E., Parker, M. O., et al. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1575360 · Cited by 26
“For example, an ‘anti-inflammatory’ microglia-inhibiting antibiotic minocycline prevents LPS-induced cytokine expression and indoleamine 2,3 dioxygenase (IDO, the tryptophandegrading enzyme), blocking both sickness- and depressionlike behaviors in mice [161].”
BackgroundQuinolinic acid potentially links kidney injury to brain toxicity
Saliba, A., Debnath, S., Tamayo, I. M., Lee, H. J., Ragi, N., Das, F., Montellano, R., Tůmová, J., Maddox, M., Trevino, E., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.180229 · Cited by 24
Self-citationAn Adrenalectomy Mouse Model Reflecting Clinical Features for Chronic Fatigue Syndrome
Lee, J.-S., Jeon, Y.-J., Park, S.-Y., & Son, C. (2020) · Biomolecules · doi:10.3390/biom10010071 · Cited by 23
“We excluded the stress-induced model because its aspects of endocrinology were not similar to those of CFS, just to the chronic fatigue or depression [34,35].”
ResultSetoyama, D., Yoshino, A., Takamura, M., Okada, G., Iwata, M., Tsunetomi, K., Ohgidani, M., Kuwano, N., Yoshimoto, J., Okamoto, Y., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.118 · Cited by 23
Xu, X. F., Shi, M. M., Luo, M. Y., Liu, D. D., Guo, D. M., Ling, C., Zhong, X. L., Xu, Y., & Cao, W. Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109092 · Cited by 24
Wang, Q., 四川大学华西医院国家老年医学临床研究中心老年医学科, 生., Zhang, X., Guo, Y.-J., Pang, Y., Li, J., Zhao, Y., Wei, J.-F., Zhu, B.-T., Tang, J.-X., et al. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.473 · Cited by 24
Inflammation and Behavior Changes in Dogs and Cats
Piotti, P., Pierantoni, L., Albertini, M., & Pirrone, F. (2023) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2023.08.006 · Cited by 26
Wang, J., Wang, Y., Chen, Y., Zhang, J., Zhang, Y., Li, S., Zhu, H., Song, X., Hou, L., Wang, L., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04438-4 · Cited by 23
Najjar, S., Pearlman, D. M., Hirsch, S., Friedman, K., Strange, J., Reidy, J., Khoukaz, M., Ferrell, R. B., Devinsky, O., Najjar, A., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.041 · Cited by 24
Dinel, A., Rey, C., Baudry, C., Fressange-Mazda, C., Ruyet, P. L., Nadjar, A., Pallet, P., Joffre, C., & Layé, S. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.08.013 · Cited by 25
Hall, S., Arora, D. S., Anoopkumar‐Dukie, S., & Grant, G. D. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b03568 · Cited by 23
Wieseler, J. L., Ellis, A., McFadden, A., Stone, K., Brown, K., Cady, S., Bastos, L. F. S., Sprunger, D. B., Rezvani, N., Johnson, K. W., et al. (2017) · Brain Research · doi:10.1016/j.brainres.2017.03.011 · Cited by 24
“…cytokines, and inducible nitric oxide, and can increase antiinflammatory cytokine expression (Lee et al., 2003; Wilkins et al., 2004; Ledeboer et al., 2005; Kim and Suh, 2009; O’Connor et al., 2009), and has been shown to have similar effects on macrophages (Zhang et al., 2009; Dutta et al., 2010).”
BackgroundMusaelyan, K., Aldridge, S., Preez, A. D., Egeland, M. T., Zunszain, P. A., Pariante, C. M., Thuret, S., & Fernandes, C. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117746902 · Cited by 24
“) injections also induces depression-like behaviour in specific behavioural tests, such as increased immobility in the forced swim test (Godbout et al., 2007; O’Connor et al., 2009) and anhedonia in the sucrose consumption test and test of sexual behaviour (Painsipp et al.”
BackgroundNikkheslat, N., Pariante, C. M., & Zunszain, P. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00003-9 · Cited by 27
Dal‐Pizzol, F., de Medeiros, G. F., Michels, M., Mazeraud, A., Bozza, F. A., Ritter, C., & Sharshar, T. (2021) · Neurotherapeutics · doi:10.1007/s13311-020-00981-9 · Cited by 26
Bahaidrah, K. A., Alzahrani, N. A., Aldhahri, R. S., Mansouri, R. A., & Alghamdi, B. S. A. (2022) · Clinical and Translational Neuroscience · doi:10.3390/ctn6030020 · Cited by 25
Hippocampal PACAP signaling activation triggers a rapid antidepressant response
Zhang, H., Sun, Y., Wu, Z., Yin, Y., Liu, R., Zhang, J., Zhang, Z., Yau, S., Wu, H., Yuan, T., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00548-1 · Cited by 40
“The latter elicits depression-like behavior plausibly through preferential conversion of tryptophan to kynurenine signaling [30, 31], a mechanism shared for depression and pain.”
BackgroundLittrell, J. L. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00297 · Cited by 25
Post stroke depression: clinics, etiopathogenesis and therapeutics
Pedroso, V. S. P., de Souza, L. C., Brunoni, A. R., & Teixeira, A. L. (2015) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/0101-60830000000041 · Cited by 30
Quantification of IDO1 enzyme activity in normal and malignant tissues
Zhai, L., Ladomersky, E., Bell, A., Dussold, C., Cardoza, K., Qian, J., Lauing, K. L., & Wainwright, D. A. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.07.006 · Cited by 24
Suento, W. J., Kunisawa, K., Wulaer, B., Kosuge, A., Iida, T., Fujigaki, S., Fujigaki, H., Yamamoto, Y., Tanra, A. J., Saito, K., et al. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15222 · Cited by 23
de Oliveira, C. M., Smedt, V. D., Morael, J., Vancassel, S., Capuron, L., Gaudout, D., Pourtau, L., & Castanon, N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122155 · Cited by 22
“Mounting evidence points to inflammation-driven alterations of the KYN and BH4 pathways as key players in the induction of depressive symptoms reported in inflammatory and/or stress conditions, due to their overall impact on 5-HT and DA metabolism, as well as increased oxidative damages and glutamate-related neurotoxi…”
BackgroundSelf-citationMicroglia as a Hub for Suicide Neuropathology: Future Investigation and Prevention Targets
de Andrade, E. G., Ibáñez, F. G., & Tremblay, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.839396 · Cited by 22
Systemic inflammation alters central 5-HT function as determined by pharmacological MRI
Couch, Y., Martin, C. J., Howarth, C., Raley, J., Khrapitchev, A. A., Stratford, M. R. L., Sharp, T., Sibson, N. R., & Anthony, D. C. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.02.046 · Cited by 23
“R. Sibson). license. inflammogens, such as the bacterial endotoxin lipopolysaccharide (LPS) and attenuatedMycobacterium bovis, have been shown to induce depressive-like symptoms, often known as sickness behaviours, in rodents and induce changes in the 5-HT system (O'Connor et al., 2009).”
InfluentialZhang, K., Zhao, Y., Chen, X., Li, Y., Lan, T., Chang, M., Wang, W., Wang, C., Zhuang, X., Zhang, B., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103836 · Cited by 23
“It is well known that lipopolysaccharide (LPS) can affect the central immunity by inducing pro-inflammatory factors and activating inflammasomes, thereby causing depressive-like behaviors in mice [54,55].”
A Comprehensive Review of Nutritional Influences on the Serotonergic System
Tang, J., Krushelnycky, L., Shaqo, A., & Cho, C. E. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100524 · Cited by 31
“IDO activation shunts Trp metabolism down the kynur-enine pathway, effectively reducing the availability of Trp for serotonin synthesis, a mechanism implicated in the link between inflammation and depression [122,123].”
Lu, L., Yang, L.-K., Yue, J., Wang, X., Qi, J., Yang, F., Feng, B., & Liu, S. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136284 · Cited by 22
Nettis, M. A., Lombardo, G., Hastings, C. N. M., Zajkowska, Z., Mariani, N., Nikkheslat, N., Sforzini, L., Worrell, C., Begum, A., Brown, M., et al. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231173588 · Cited by 23
“For instance, in rats injected with lipopolysaccharide, the administration of minocycline appeared to block IDO indirectly, by attenuating lipopolysaccharide-induced proinflammatory response and thus preventing the development of depressive-like behaviours (O’Connor et al., 2009).”
BackgroundWang, Z., Li, W., Chen, J., Shi, H., Zhao, M., You, H., RAO, C., ZHAN, Y., Yang, Y., & Xie, P. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4741 · Cited by 22
“1A), and the AIR mice exhibited a significant decrease in the total distance travelled in the OFT test, as compared with the control group (Fig.”
InfluentialWah, D. T. O., Kavaliers, M., Bishnoi, I. R., & Ossenkopp, K. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.003 · Cited by 24
“Body weight decrease [16,20] was used as an indicator of an LPSinduced sickness response.”
Ni, S., Huang, H., He, D., Chen, H., Wang, C., Zhao, X., Chen, X., Cui, W., Zhou, W., & Zhang, J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14670 · Cited by 24
Wu, M., Lin, C., Chiu, D., & Chen, S. (2020) · Diagnostics · doi:10.3390/diagnostics10040207 · Cited by 21
“However, IDO is potently induced by proinflammatory cytokines and acts locally to modulate Trp levels in response to inflammation [26,28].”
BackgroundGüngör, B. B., Akgul, A. I., Taymur, İ., Demirci, H., & İnel, A. (2020) · Psychiatria Danubina · doi:10.24869/psyd.2020.105 · Cited by 23
Tetrahydrobiopterin modulates the behavioral neuroinflammatory response to an LPS challenge in mice
Vancassel, S., Fanet, H., Castanon, N., de Oliveira, C. M., Cussotto, S., & Capuron, L. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.06.016 · Cited by 30
Self-citationInhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012–2015)
Zádori, D., Veres, G., Szalárdy, L., Klivènyi, P., Fülöp, F., Toldi, J., & Vécsei, L. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1189531 · Cited by 21
“[56] Furthermore, inhibition of IDO with compound 1 abrogated systemic inflammation-induced depressive behavior in mice.[57,58] The genetic ablation or compound 1-induced inhibition of”
BackgroundVariation of genes encoding KAT1, AADAT and IDO1 as a potential risk of depression development
Wigner, P., Czarny, P. L., Synowiec, E., Bijak, M., Talarowska, M. E., Gałecki, P., Szemraj, J., & Śliwiński, T. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.05.001 · Cited by 21
Duan, K., Wang, S., Yin, J., Li, X., Ma, J., Huang, Z., Zhou, Y., Yu, H., Yang, M., Zhou, H., et al. (2018) · Archives of Women s Mental Health · doi:10.1007/s00737-018-0898-y · Cited by 22
Modulation of the Nitric Oxide/BH4 Pathway Protects Against Irradiation-Induced Neuronal Damage
Thabet, N. M., Rashed, E. R., Abdel-Rafei, M. K., & Moustafa, E. M. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03306-0 · Cited by 20
Yu, H., Kan, J., Tang, M., Zhu, Y., & Hu, B. (2023) · Brain Sciences · doi:10.3390/brainsci13040549 · Cited by 21
Deore, R., Ansari, R., Awathale, S. N., Shelke, M., Badwaik, H. R., Goyal, S. N., & Nakhate, K. T. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176707 · Cited by 21
Hasegawa, M., Kunisawa, K., Wulaer, B., Kubota, H., Kurahashi, H., Sakata, T., Ando, H., Fujigaki, S., Fujigaki, H., Yamamoto, Y., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17407 · Cited by 20
Relationship Between Obesity and Depression Considering the Inflammatory Theory
Oracz, A. J., Zwierz, M., Naumowicz, M., Suprunowicz, M., & Waszkiewicz, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26114966 · Cited by 24
“Indeed, the elevated activity of proinflammatory IDO1 is closely linked with the modulation of immune and metabolic responses, as shown in studies conducted in a mouse model of induced lipopolysaccharide (LPS) and depression-like behavioral symptoms [47].”
Elnahas, E. M., Zeid, M. S. A., Kawy, H. S. A., Hendawy, N., & Baher, W. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.08.027 · Cited by 21
Hodges, S. L., Nolan, S. O., Tomac, L. A., Muhammad, I. D. A., Binder, M. S., Taube, J. H., & Lugo, J. N. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112776 · Cited by 21
Kirsten, T. B., Cabral, D., Galvão, M. C., Monteiro, R., Bondan, E. F., & Bernardi, M. M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.019 · Cited by 23
Neuroimmune Genes and Alcohol Drinking Behavior
Harris, R. A., & Blednov, Y. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_13 · Cited by 21
Schwamborn, R., Brown, E., & Haase, J. K. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13596 · Cited by 21
Obesity after neonatal overfeeding is independent of hypothalamic microgliosis
Soch, A., Sominsky, L., Luca, S. N. D., & Spencer, S. J. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12757 · Cited by 21
Kim, A., Jung, H., Kim, Y.-E., Kim, S. C., Park, J., Lee, S., & Hwang, E. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235902 · Cited by 21
“Int restingly, immobility was significantly reduced in th LPS-treated nCTL in the TST test (Bonferroni’s post hoc; p = 0.0003), but there was no significant difference in the LPS-treated nCre mice (Bonferroni’s post hoc; p = 0.7164) (Figure 4G).”
MethodInfluentialLotter, J., Möller, M., Dean, O. M., Berk, M., & Harvey, B. H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00121 · Cited by 21
“Indeed, LPS-exposed offspring presented with significant depressivelike behaviors (increased immobility) (Figure 4A) and reduced active coping (swimming and climbing) (Figures 4B,C), in agreement with earlier studies (101, 102).”
ResultAcross Barriers: Blood–Brain and Gut Barrier Signaling in Psychiatric Disorders
Binder, L. B., Bevilacqua, L. M., Thomassen, F. G. L., Lebel, M., Jensen, B. A. H., & Ménard, C. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70282 · Cited by 20
Immune-brain plasticity underpins stress and affective behaviors
Lee, J., & Wheeler, M. E. (2025) · Neuron · doi:10.1016/j.neuron.2025.11.020 · Cited by 21
Brás, J. P., Pinto, S., Almeida, M. I., Prata, J., von Doellinger, O., Coelho, R. C., Barbosa, M. A., & Santos, S. G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_28 · Cited by 20
Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
McCallum, R. T., & Perreault, M. L. (2021) · Cells · doi:10.3390/cells10092270 · Cited by 21
Li, R., Chen, X., Ye, H., & Sheng, X. (2024) · South African Journal of Botany · doi:10.1016/j.sajb.2023.12.029 · Cited by 21
Yu, Y., Zhu, W., Liang, Q., Jing, L. I. U., Yang, X., & Sun, G. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.05.001 · Cited by 19
Chan, S. Y., Capitão, L. P., Probert, F., Klinge, C., Höckner, S., Harmer, C. J., Cowen, P. J., Anthony, D. C., & Burnet, P. W. J. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0818-6 · Cited by 21
Souza, L. C., de Brito, M. L. O., Jessé, C. R., Boeira, S. P., de Gomes, M. G., Goes, A. T. R., Fabbro, L. D., Machado, F. R., Prigol, M., & Nogueira, C. W. (2020) · Steroids · doi:10.1016/j.steroids.2020.108727 · Cited by 21
Zhao, Y. H., Sun, X., Zhang, T., Liu, S., Cai, E., & Zhu, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111387 · Cited by 19
Decreased kynurenine pathway potentiate resilience to social defeat effect on cocaine reward
Giménez‐Gómez, P., Ballestín, R., de Biedma‐Elduayen, L. G., Vidal, R., Perez, C. F., Reguilón, M. D., O’Shea, E., Miñarro, J., Colado, M. I., & Rodríguez‐Arias, M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108753 · Cited by 19
Lai, Y., Dhingra, R., Zhang, Z., Ball, L. M., Zylka, M. J., & Lü, K. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00656 · Cited by 23
Ramalho, J. B., Spiazzi, C. C., Bicca, D. F., Rodrigues, J. F., Sehn, C. P., da Silva, W. P., & Cibin, F. W. S. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113847 · Cited by 20
Targeting the kynurenine pathway as a potential strategy to prevent and treat Alzheimer’s disease
Gong, C.-Y., Li, Z., Wang, H., Liu, J., Chen, L., Zhang, H.-W., Wang, X., & Yang, J. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.05.022 · Cited by 21
“Some studies showed that depression in patients or depressive-like behavior in animals, which are defined as neuroinflammatory diseases, are relative with over-expression IDO induced by Bacille Calmette-Guerin [22], Lipopolysaccharide [23] or INF [24], and pretreatment with the competitive IDO inhibitor 1-methyltrypto…”
BackgroundŞahin, C., Dursun, S. M., Çetin, M., & Arıcıoğlu, F. (2016) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20160520092044 · Cited by 29
Saeidienik, F., Shahraki, M. R., Fanaei, H., & Badini, F. (2018) · Basic and Clinical Neuroscience Journal · doi:10.29252/nirp.bcn.9.3.209 · Cited by 19
Identification of a microglial activation-dependent antidepressant effect of amphotericin B liposome
Gao, M., Hu, P., Cai, Z., Wu, Y. H., Wang, D., Hu, W., Xu, X., Zhang, Y.-R., Lu, X., Chen, D., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.005 · Cited by 19
Burek, D., Massaly, N., Doering, M. M., Zec, A., Gaelen, J. I., & Morón, J. A. (2021) · Pain · doi:10.1097/j.pain.0000000000002179 · Cited by 18
“Complete Freund’s adjuvant–induced persistent pain has long been an effective tool for studying inflammation and nociception; however, our understanding of the degree to which this condition impacts activity and behavior remains inconclusive.(12,41,49) Although some studies have observed disturbances in sleep, gait, a…”
BackgroundTian, J., Wang, Z., Ren, Y., Jiang, Y. H., Zhao, Y., Li, M., & Zhang, Z. (2022) · Neural Plasticity · doi:10.1155/2022/2847672 · Cited by 19
“At present, LPS, the primary component of the outer membrane of Gram-negative bacteria, is commonly employed to induce depressive-like states in rodents [21, 22].”
BackgroundSmaniotto, T. Â., Casaril, A. M., Lourenço, D. D. A., Sousa, F. S. S., Seixas, F. K., Collares, T. V., Woloski, R., Pinto, L. D. S., Alves, D. A. C., & Savegnago, L. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06336-4 · Cited by 21
Gao, Y., Pan, K., Zhang, Y.-M., Qi, Y., Chen, W.-G., Zhou, T. J., Zong, H.-C., Guo, H., Zhao, J.-W., Liu, X., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01384-8 · Cited by 20
Qiao, C.-M., Ma, X., Tan, L., Xia, Y.-M., Li, T., Wu, J., Cui, C., Zhao, W.-J., & Shen, Y. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115142 · Cited by 20
Dietary tryptophan supplementation and affective state in pigs
Stracke, J., Otten, W., Tuchscherer, A., Witthahn, M., Metges, C. C., Puppe, B., & Düpjan, S. (2017) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2017.03.009 · Cited by 20
“, 2010) independent of 5-HT levels (O’Connor et al., 2008; Castanon, 2015).”
BackgroundOliveros, A., Wininger, K. M., Sens, J. P., Larsson, M. K., Liu, X. C., Choi, S., Faka, A., Schwieler, L., Engberg, G., Erhardt, S., et al. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.09.010 · Cited by 20
Involvement of Kynurenine Metabolism in Bipolar Disorder: An Updated Review
Zhang, P., Huang, H., Gao, X., Jiang, J., Xi, C., Wu, L., Fu, Y., Lai, J., & Hu, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.677039 · Cited by 21
“As indicated by two landmark studies, administration of lipopolysaccharide (LPS) failed to elicit depressive-like behaviors when the stimulation of the kynurenine (KYN) pathway was blocked, despite that the levels of proinflammatory cytokines were elevated (10, 11).”
ResultPeripheral Biomarkers in Animal Models of Major Depressive Disorder
Carboni, L. (2013) · Disease Markers · doi:10.1155/2013/284543 · Cited by 20
“As another example, to investigate the mechanism of the association between increased ratio of plasma kynurenine to tryptophan and depressive symptoms, measures of the levels of these analytes were carried out alongside behavioural tests in animalmodels based on the acute activation of the peripheral innate immune sys…”
MethodBhatt, S., Mahesh, R., Devadoss, T., & Jindal, A. (2016) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2016-0083 · Cited by 18
“These results strengthen the proposed mechanism for compound 6g such that it may influence the serotonergic transmission by inhibiting the increased levels of inflammatory mediators responsible for degradation of tryptophan by highly activated IDO enzyme at the periphery [3, 12, 13].”
BackgroundInfluentialThe Microbiota-gut-immune-glia (MGIG) Axis in Major DepressionPreprint
Rudzki, L., & Maes, M. H. J. (2020) · Preprints.org · doi:10.20944/preprints202002.0084.v1 · Cited by 18
Metadata
- Authors
- O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Dantzer, R
- Venue
- Molecular Psychiatry
- Published
- 2008-01-15
- Volume
- 14
- Issue
- 5
- Pages
- 511-522
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2683474
- OpenAlex
- W2050508296
- Cited by
- 1,278
- References
- 56
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 82 · 2023: 86 · 2022: 94 · 2021: 106 · 2020: 88 · 2019: 86 · 2018: 95 · 2017: 87 · 2016: 88 · 2015: 76 · 2014: 61 · 2013: 71 · 2012: 38
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG029573)
- National Institute of Mental Health (R01MH079829, R01MH071349, R01 MH-71349)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK059802, T32 DK59802-01)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- indoleamine 2,3-dioxygenase, lipopolysaccharide, depression-like behavior, kynurenine pathway, tryptophan catabolism, minocycline, 1-methyltryptophan, L-kynurenine, kynurenine/tryptophan ratio, serotonin turnover, inflammatory cytokines, comorbid depression
- MeSH terms
- Animals, Behavior, Animal, Chromatography, High Pressure Liquid, Cytokinins, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Gene Expression Regulation, Kynurenine, Lipopolysaccharides, Male, Mice, Inbred ICR, Minocycline, Motor Activity, Swimming, Time Factors, Tryptophan, Hindlimb Suspension, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.